Bafna Pharmaceuticals Limited has informed the Exchange that the Members at the 30th Annual General Meeting of the Company held on September 19, 2025 had inter-alia approved (i) Appointment of Mr. Navin Kumar as Independent Director of the Company and (ii) Re-appointment of Mr. Palamadai Krishnan Sundaresan and Mrs. Ravichandran Chitra as Independent Directors of the Company